We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Combination Therapy of L19IL2 and Gemcitabine in Advanced Pancreatic Cancer Patients

This study has been terminated.
(lack of recruitment)
Sponsor:
ClinicalTrials.gov Identifier:
NCT01198522
First Posted: September 10, 2010
Last Update Posted: November 20, 2014
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by (Responsible Party):
Philogen S.p.A.
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been terminated.
  Study Completion Date: November 2014
  Primary Completion Date: November 2014 (Final data collection date for primary outcome measure)